Burroughs Amy L.'s Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Feb 18, 2026
- Accession no.
- 0001872564-26-000006
- Filed
- Feb 18, 2026
- Trade date
- Feb 17, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $571.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burroughs Amy L.CIK 0001872564 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseAcquired | +14,583 | $4.64 | +$67,665.12 | 303,559 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −2,341 | $38.07 | −$89,121.87 | 301,218 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −8,159 | $39.22 | −$319,995.98 | 293,059 | Direct | |
| Feb 17, 2026 | Common Stock | SSaleDisposed | −4,083 | $39.80 | −$162,503.4 | 288,976 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | Common Stock | MOption exerciseDisposed | −14,583 | $0.00 | $0 | 970,117 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.